top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in the Treatment of Renal Cell Carcinoma
Advances in the Treatment of Renal Cell Carcinoma
Autore Reynolds Paul
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (221 p.)
Soggetto topico Medicine
Soggetto non controllato renal cell carcinoma
autophagy
hydroxychloroquine
chloroquine
ROC-325
cysteine cathepsins
cysteine cathepsin inhibitors
lysosome
renal cancer
metastatic renal cell carcinoma
immune-based combination therapies
network meta-analysis
PD-L1
predictive
biomarker
treatment
TKIs
mRCC
biomarkers
soluble factors
immunotherapy
renal cell carcinoma (RCC)
sunitib resistance
artesunate (ART)
Traditional Chinese Medicine (TCM)
growth inhibition
ferroptosis
reactive oxygen species (ROS)
clear cell renal cell carcinoma
ccRCC
RCC
kidney cancer
evolution
evolutionary trajectory
metastatic
second line therapy
renal cell cancer
immune checkpoint inhibitors
tyrosine kinase inhibitors
individualization
genomic signature
transcriptomic analysis
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557615503321
Reynolds Paul  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Application of Bioinformatics in Cancers
Application of Bioinformatics in Cancers
Autore Brenner J. Chad
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (418 p.)
Soggetto non controllato cancer treatment
extreme learning
independent prognostic power
AID/APOBEC
HP
gene inactivation biomarkers
biomarker discovery
chemotherapy
artificial intelligence
epigenetics
comorbidity score
denoising autoencoders
protein
single-biomarkers
gene signature extraction
high-throughput analysis
concatenated deep feature
feature selection
differential gene expression analysis
colorectal cancer
ovarian cancer
multiple-biomarkers
gefitinib
cancer biomarkers
classification
cancer biomarker
mutation
hierarchical clustering analysis
HNSCC
cell-free DNA
network analysis
drug resistance
hTERT
variable selection
KRAS mutation
single-cell sequencing
network target
skin cutaneous melanoma
telomeres
Neoantigen Prediction
datasets
clinical/environmental factors
StAR
PD-L1
miRNA
circulating tumor DNA (ctDNA)
false discovery rate
predictive model
Computational Immunology
brain metastases
observed survival interval
next generation sequencing
brain
machine learning
cancer prognosis
copy number aberration
mutable motif
steroidogenic enzymes
tumor
mortality
tumor microenvironment
somatic mutation
transcriptional signatures
omics profiles
mitochondrial metabolism
Bufadienolide-like chemicals
cancer-related pathways
intratumor heterogeneity
estrogen
locoregionally advanced
RNA
feature extraction and interpretation
treatment de-escalation
activation induced deaminase
knockoffs
R package
copy number variation
gene loss biomarkers
cancer CRISPR
overall survival
histopathological imaging
self-organizing map
Network Analysis
oral cancer
biostatistics
firehose
Bioinformatics tool
alternative splicing
biomarkers
diseases genes
histopathological imaging features
imaging
TCGA
decision support systems
The Cancer Genome Atlas
molecular subtypes
molecular mechanism
omics
curative surgery
network pharmacology
methylation
bioinformatics
neurological disorders
precision medicine
cancer modeling
miRNAs
breast cancer detection
functional analysis
biomarker signature
anti-cancer
hormone sensitive cancers
deep learning
DNA sequence profile
pancreatic cancer
telomerase
Monte Carlo
mixture of normal distributions
survival analysis
tumor infiltrating lymphocytes
curation
pathophysiology
GEO DataSets
head and neck cancer
gene expression analysis
erlotinib
meta-analysis
traditional Chinese medicine
breast cancer
TCGA mining
breast cancer prognosis
microarray
DNA
interaction
health strengthening herb
cancer
genomic instability
ISBN 3-03921-789-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367743403321
Brenner J. Chad  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biomarkers Used for the Diagnosis of Diseases
Biomarkers Used for the Diagnosis of Diseases
Autore Nimse Satish Balasaheb
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (120 p.)
Soggetto topico Research & information: general
Soggetto non controllato SERS
LPS
bacteria
endotoxin
lipid A
silver nanorods
creatinine
ZnO nanowires
piezo-enzymatic-reaction effect
self-powered biosensor
immunosensors
electrochemical immunosensors
biosensors
voltammetric immunosensors
amperometric immunosensors
impedimetric immunosensors
eletrochemiluminescent immunosensors
cysteine
biothiols
cystinuria
portable
fluorimeter
bio-imaging
cancer
bladder cancer
prostate cancer
urinary biomarkers
urinary VOCs
machine olfaction
GC-IMS
GC-TOF-MS
cancer markers
immune checkpoints
PD-1
PD-L1
high-aspect-ratio microfluidic channel
parallelogram cross-section
monodisperse droplet
droplet generation
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566479803321
Nimse Satish Balasaheb  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Immunology
Cancer Immunology
Autore Subramanian Subree
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (316 p.)
Soggetto topico Medicine
Soggetto non controllato NKG2D
CAR T
IL-7
prostate cancer
cell therapy
CD19-CAR-T
B cell aplasia
KIR
PD-1
inhibitory CAR
tumor-infiltrating lymphocytes
tumor microenvironment
immunotherapy
NK cells
cancer stem cells (CSCs)
antibody-dependent cellular cytotoxicity (ADCC)
differentiation
cytotoxicity
IFN-γ
osteoclasts
MICA/B mAb
DNA methylation
RNA methylation
S-adenosylmethionine (SAM)
cancer
innate immunity
adaptive immunity
T cells
m6A
PD-L1
resistance
immune checkpoints
cancer vaccine
combination immunotherapy
TCR diversity
organ transplantation
carcinoma
epidemiologic studies
immunosuppression
CTLA-4
Treg cells
immune checkpoint inhibitors
CD28
antigen-presenting cells
IL15
colon cancer
melanoma
uveal
BAP1
anti-PD-1
anti-CTLA-4
TIL
classical and endemic Kaposi Sarcoma
systemic treatment
multi-state modelling
treatment free interval
chemotherapy
interferon
triple negative breast cancer
immunomodulation
bispecific antibody
sortase A
chemo-enzymatic approach
anti-CD20 antibody
Fab
BiFab
colorectal cancer
dendritic cells
Atypical Chemokine Receptor 4 (ACKR4)
T-cell priming
immune checkpoint blockade
primary liver cancer
kynurenine pathway
immune evasion
indoleamine 2,3 dioxygenase 1
tryptophan 2,3 dioxygenase 2
IDO inhibitor
antigen presenting cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557349203321
Subramanian Subree  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Nanomedicine
Cancer Nanomedicine
Autore Hoskins Clare
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (510 p.)
Soggetto topico Technology: general issues
Soggetto non controllato antibody drug conjugate (ADC)
PD-L1
tumor spheroid disruption
immune modulation
doxorubicin
graphene oxide
adsorption
cathepsin D
cathepsin L
anti-metastatic enzyme cancer therapy
nanoparticles
targeted delivery system
siRNA
osteopontin
mammary carcinoma
mesenchymal stem cells (MSCs)
TAT peptide
PLGA
paclitaxel
nano-engineered MSCs
orthotopic lung tumor model
intracranial glioma
immunotherapy
CPMV
viral nanoparticles
in situ vaccine
albumin nanoparticles
microbubble
ultrasound
theranostics
hepatocellular carcinoma
VX2 tumor
intra-arterial chemotherapy
lung cancer
nanomedicine
clinical status
cancer therapy
breast cancer
cell signaling
active targeting
passive targeting
EPR effect
oncogenes
nanoparticle
drug delivery
ligand
tumor targeting
biodistribution
Mesoporous silica nanoparticle
drug delivery system
target treatment
lanthanide metal
hyaluronic acid
hyaluronidase
drug combination
everolimus
dual-targeting
magnetic nanoparticles
monoclonal antibodies
nanostructured lipid carrier
platelet membrane
biomimicry
plasmonic photothermal therapy
gold nanorods
surgery
bleeding
dogs
cats
stimuli-responsive
DOX
SN38
CSCs
single-walled carbon nanotubes
chirality separation
NASH
drug-gene delivery
near IR hyperspectral imaging
plasmonics
copper
VEGF
glioblastoma
differentiated neuroblastoma
peptidomimetics
real-time quantitative polymerase chain reaction (qPCR)
actin
combinatorial therapy
anticancer and antibacterial activity
temoporfin
drug-in-cyclodextrin-in-liposome
hybrid nanoparticles
multicellular tumor spheroids
cyclodextrins
photodynamic therapy article
yet reasonably common within the subject discipline
antitumor strategy
biomimetic core–shell nanoparticles
NK cell-derived exosomes
folate receptor
albumin nanoparticle
microfluidic
cabazitaxel
polydopamine nanoparticles
size
cytotoxicity
iron affinity
FA-DABA-SMA
self-assembly
oncogenic proteins
intracellular disruption
folic receptor alpha
pancreatic cancer
parvifloron D
albumin
erlotinib
photodynamic therapy
lipid nanoparticles
tumor vectorization
verteporfin
ovarian carcinomatosis
spheroids
integrin
RGD peptide
cancer diagnosis
radiotherapy
hyperthermia therapy
biomimetic
nanocarrier
membrane-wrapped
cancer
targeted delivery
photothermal therapy
imaging
cancer nanomedicine
tumor microenvironment
nano–bio interactions
clinical translation
magnetic nanowires
magnetic hyperthermia
magnetic actuation
magnetic drug targeting
titanate nanotubes
gold nanoparticles
vectorization
colloidal stability
docetaxel
prostate cancer
mangiferin
anti-topoisomerase activity
extracellular vesicles
exosomes
chemico-physical functionalization
loading
translational medicine
nanotechnology: bioengineering
anacardic acid
mitoxantrone
targeted drug delivery
liposomes
melanoma
apoptosis
ascorbic acid
angiogenesis
epithelial-to-mesenchymal transition
hypoxia
immunosuppression
metabolism
nanotherapeutics
tumour microenvironment
DNA origami
liposome
remote loading
acute toxicity
organoids
magnetic silica-coated iron oxide nanochains
photothermal treatment
hyperthermia
collagen
cellular microenvironment
lymphadenectomy
magnetometer
sentinel lymph node dissection
SPION
superparamagnetic iron oxide nanoparticles
Vδ2 T cells
zoledronic acid
polymeric nanoconstruct
anti-tumor immunity
colorectal carcinoma
β-cyclodextrin nanosponges
BALB-neuT mice
brain tumours
glioma
blood brain barrier
polymeric nanoparticles
PEGylation
dioleoylphosphatidylethanolamine
poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer
folate
oxidation-sensitive release
cellular interaction
in vitro anti-cancer activity
triple negative breast cancer
organotin
mesoporous silica nanoparticles
MDA-MB-231
theranostic nanomaterials
nanobiotechnology
molecular imaging
nanosystems
nanomicelles
ovarian cancer
tumour targeting
chemotherapeutics
riboflavin
vitamin B2
nanomedicines
secondary structure
mixed micelle
pH responsive
targeted therapy
anti-cancer
shear stress
flow
in vitro
therapeutics
diagnostics
Immunotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114703321
Hoskins Clare  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cross Talk between Lymph Node Lymphatic Endothelial Cells and T Cells in Inflammation and Cancer
Cross Talk between Lymph Node Lymphatic Endothelial Cells and T Cells in Inflammation and Cancer
Autore Silvia Della Bella
Pubbl/distr/stampa Frontiers Media SA, 2017
Descrizione fisica 1 electronic resource (100 p.)
Collana Frontiers Research Topics
Soggetto non controllato Liver Injury
Lymphatic Vessels
Lymphatic Vasculature
Tumor Microenvironment
PD-L1
Antigen Presenting Cells
Lymphatic Endothelial Cells
T cell trafficking
T cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910261134703321
Silvia Della Bella  
Frontiers Media SA, 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Marine Drug Research in China: Selected Papers from the 15-NASMD Conference
Marine Drug Research in China: Selected Papers from the 15-NASMD Conference
Autore Zhou Xuefeng
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (512 p.)
Soggetto topico Medicine
Soggetto non controllato Antarctic krill (Euphausia superba)
peptide
antioxidant activity
stability
oyster
plasma
peptidome
antimicrobial peptides
cytotoxicity
actinomycete
piericidins
absolute configuration
Pestalotiopsis heterocornis
heterocornols
anti-inflammatory activity
sponge-derived fungus
sclerotides
lipodepsipeptide
Aspergillus sclerotiorum
nasopharyngeal carcinoma
AChE inhibitory
vascular endothelial cell
flavonoid
oxidized low-density lipoprotein
Nrf2
apoptosis
butyrolactone I
food allergy
metabolism
pharmacokinetics
actinomycin X2
microbial pigments
dyeing
silk
antibacterial properties
PD-L1
virtual screening
pharmacophore modeling
ADME
molecular dynamics
xanthones
ascidian-derived fungus
Diaporthe sp
anti-glioma activity
antiaging
Sonneratia apetala
signaling pathway
Caenorhabditis elegans
mutants
coral-derived fungi
Aspergillus hiratsukae
meroterpenoids
antibacterial activity
cytotoxic activity
deep-sea-derived fungus
Aspergillus puniceus
isoquinoline alkaloid
protein tyrosine phosphatase inhibitor
antibacterial
Aspergillus sp
geodin
semisynthesize
insecticidal activity
Arca inflata
antitumor peptide
MAPK signaling
calmodulin
colorectal cancer
methicillin-resistant Staphylococcus aureus
actinomycin D
Streptomyces parvulus
mechanism
mangrove endophytic Pestalotiopsis
Sdy-1
antitumor activity
Wnt signaling
β-catenin
eremophilane sesquiterpenoids
mangrove-derived fungus
Penicillium sp
Oceanapia
sponge
secondary metabolites
biological activities
drug design
anticancer
cyclic pentapeptide
galaxamide analogues
skipjack tuna (Katsuwonus pelamis) muscle
angiotensin-I-converting enzyme (ACE) peptide
molecular docking
nitric oxide (NO)
endothelin-1 (ET-1)
Trichoderma longibrachiatum
sesquiterpene glycoside
antimicrobial activity
marine fungi
Aspergillus unguis
depsides
depsidones
osteoclast differentiation
soft-coral-derived fungus
pyranodipyran derivatives
tyrosyl DNA phosphodiesterase 1 inhibitory activities
fluorescent properties
butenolides
enantiomers
Aspergillus terreus
pancreatic lipase
NAFLD
fucoxanthin
adenosine monophosphate-activated protein kinase (AMPK)
nuclear factor erythroid-2-related factor 2-mediated (Nrf2)
Toll-like receptor 4-mediated (TLR4)
Aspergillus flavipes HN4-13
emodin
macroporous resin XAD-16
adsorption kinetics and isotherms
enrichment
tetramic acid derivatives
deep-sea fungus
clavipitacae
Lecanicillium fusisporum
chronic kidney disease
fucoidan
cognitive dysfunction
neuroinflammation
oxidative stress
GSK3β-Nrf2-HO-1 signaling
microglial polarization
deep-sea actinomycetes
aromatic acids
oximes
antihyperlipidemic
phycocyanin
microbiota
transcriptome
IL-17 pathway
Hahella
prodiginine
chejuenlide
genome mining
LC-MS/MS
CDK4/6
marine compounds
pharmacophore construction
ADMET
mm-pbsa
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Marine Drug Research in China
Record Nr. UNINA-9910595071903321
Zhou Xuefeng  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Autore Uchino Junji
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (258 p.)
Soggetto topico Medicine
Soggetto non controllato non-small cell lung cancer
previously treated patients
phase I/II trial
chemotherapy
docetaxel
S-1
immunotherapy
rechallenge
retrospective analysis
pulmonary pleomorphic carcinoma
prognostic factor
glucose transporter 1
lung cancer
multiple cancers
metastasis
sequencing
mutation
genomic diagnosis
FDG-PET
immune checkpoint inhibitor
PD-1
prognosis
RAD51B methylation
PD-L1 expression
predictive biomarker
PD-1 blockade
interstitial lung disease
pulmonary fibrosis
radiology and other imaging
non-small-cell lung cancer
epidermal growth factor receptor
tyrosine kinase inhibitors
TP53 mutations
responsiveness
targeted therapy
network meta-analysis
stage IIIA-N2
surgery
immune checkpoint inhibitors
biomarker
nonsmall cell lung cancer
HIP1R
PD-L1
RUNX1
methylation
survival
EGFR-TKI
T790M
osimertinib
immune-related adverse events
endocrine disorders
tumor-bearing patients
PD-1 inhibitors
PD-L1 inhibitors
meta-analysis
nivolumab
Expanded Access Program
real-world data
daily practice
prognostic factors
NSCLC
KRAS
DNA polymerase beta
platinum-based first-line
adjuvant chemotherapy
β-catenin
lung neoplasms
nucleotide-diphosphate kinase
recurrence
unresectable
salvage surgery
oligometastasis
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Non-small Cell Lung Cancer
Record Nr. UNINA-9910557489703321
Uchino Junji  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Oncolytic Virus Immunotherapy
Oncolytic Virus Immunotherapy
Autore Marchini Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (366 p.)
Soggetto topico Medicine
Clinical & internal medicine
Soggetto non controllato oncolytic viruses
melanoma
immunotherapy
checkpoint inhibitors
combinatory therapy
reovirus
oncolytic virus
adenovirus
oncolytic
virotherapy
targeting
immunogenic cell death
αvβ6 integrin
oncolytic adenovirus
cancer immunotherapy
multi-stage
immunostimulatory
arming
HSV-1
clinical trials
newcastle disease virus
NDV
cancer
immune checkpoint inhibitor
PD-1
PD-L1
CTLA-4
type I interferon
herpes simplex virus
retargeted virus
tropism retargeting
tumor
checkpoint inhibitor
vaccination
antigen-agnostic vaccination
HER2
parvovirus
tumor microenvironment
combination therapy
glioblastoma
pancreatic cancer
colorectal cancer
measles virus
vector engineering
immune checkpoint blockade
antitumor immune response
delivery
genetic modification
biomarkers
personalized oncolyticvirotherapy
class I HLA
immunosurveillance
immunoediting
oncogenic signaling
RAS
DNA methyltransferase inhibitor (DNMTi)
viral mimicry
epigenetic silencing
adoptive T cell therapy
CAR T cell
pancreatic ductal adenocarcinoma
vesicular stomatitis virus
small molecule
cancer immune therapy
cancer therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566462203321
Marchini Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pleiotropic Action of Selenium in the Prevention and Treatment of Cancer, and Related Diseases
Pleiotropic Action of Selenium in the Prevention and Treatment of Cancer, and Related Diseases
Autore Rustum Youcef M
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (166 p.)
Soggetto non controllato isoselenourea
malignant
chemotherapeutics
epigenetics
antitumor activity
methylseleninic acid
mTOR inhibitors
tumor heterogeneity
hypoxia
ER stress
melanoma
EMT
lipid peroxidation
immune evasion
hypoxia-inducible factors (HIFs)
selenium-binding protein 1
glutathione
DNA damage
hSP56
apoptosis
tocopherol
anticancer
viability
SELENBP1
selenium
clear-cell renal cell carcinoma microRNAs
SBP1
entosis
PD-L1
miRNA
cancer stem cells
cell plasticity
disease
clear cell renal cell carcinoma
HIF
head and neck cancer
selenium species
VEGF
STAT3
hypoxia-inducible factor
methylselenocysteine
anticancer agent
Se-containing nanoparticles
DNA damage and repair
radiation
seleno-l-methionine
cancer
tumor microenvironment
methylselenoesters
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346851003321
Rustum Youcef M  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui